Journal of Signal Transduction [115] S. V. Forcales and P. L. Puri, “Signaling to the chromatin during skeletal myogenesis: novel targets for pharmacological modulation of gene expression,” Seminars in Cell and Devel- opmental Biology, vol. 16, no. 4-5, pp. 596–611, 2005. [116] S. Messina, D. Altavilla, M. Aguennouz et al., “Lipid peroxi- dation inhibition blunts nuclear factor-κB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice,” American Journal of Pathology, vol. 168, no. 3, pp. 918–926, 2006. [117] A. Toscano, S. Messina, G. M. Campo et al., “Oxidative stress in myotonic dystrophy type 1,” Free Radical Research, vol. 39, no. 7, pp. 771–776, 2005. [118] S. Fulle, F. Protasi, G. Di Tano et al., “The contribution of reactive oxygen species to sarcopenia and muscle ageing,” Experimental Gerontology, vol. 39, no. 1, pp. 17–24, 2004. [119] M. Buck and M. Chojkier, “Muscle wasting and dediﬀer- entiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants,” EMBO Journal, vol. 15, no. 8, pp. 1753– 1765, 1996. [120] E. Ardite, J. A. Barbera, J. Roca, and J. C. Ferna´ndez-Checa, “Glutathione depletion impairs myogenic diﬀerentiation of murine skeletal muscle C2C12 cells through sustained NF- κB activation,” American Journal of Pathology, vol. 165, no. 3, pp. 719–728, 2004. [121] S. Dedieu, G. Maze`res, P. Cottin, and J. J. Brustis, “Involve- ment of myogenic regulator factors during fusion in the cell line C2C12,” International Journal of Developmental Biology, vol. 46, no. 2, pp. 235–241, 2002. [122] J. Ishibashi, R. L. Perry, A. Asakura, and M. A. Rudnicki, “MyoD induces myogenic diﬀerentiation through coopera- tion of its NH 2- and COOH-terminal regions,” Journal of Cell Biology, vol. 171, no. 3, pp. 471–482, 2005. [123] M. Louis, R. Van Beneden, M. Dehoux, J. P. Thissen, and M. Francaux, “Creatine increases IGF-I and myogenic regulatory factor mRNA in C 2C12 cells,” FEBS Letters, vol. 557, no. 1–3, pp. 243–247, 2004. [124] P. Pawlikowska, B. Gajkowska, J. F. Hocquette, and A. Orze- chowski, “Not only insulin stimulates mitochondriogenesis in muscle cells, but mitochondria are also essential for insulin-mediated myogenesis,” Cell Proliferation, vol. 39, no. 2, pp. 127–145, 2006. [125] D. Thaloor, K. J. Miller, J. Gephart, P. O. Mitchell, and G. K. Pavlath, “Systemic administration of the NF-κB inhibitor curcumin stimulates muscle regeneration after traumatic injury,” American Journal of Physiology—Cell Physiology, vol. 277, part 1, no. 2, pp. C320–C329, 1999. [126] D. Coletti, V. Moresi, S. Adamo, M. Molinaro, and D. Sassoon, “Tumor necrosis factor-α gene transfer induces cachexia and inhibits muscle regeneration,” Genesis, vol. 43, no. 3, pp. 120–128, 2005. [127] F. Mourkioti, P. Kratsios, T. Luedde et al., “Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration,” Journal of Clinical Investigation, vol. 116, no. 11, pp. 2945–2954, 2006. [128] P. Goichberg, M. Shtutman, A. Ben-Ze’ev, and B. Geiger, “Recruitment of β-catenin to cadherin-mediated intercellu- lar adhesions is involved in myogenic induction,” Journal of Cell Science, vol. 114, part 7, pp. 1309–1319, 2001. [129] Y. P. Li, R. J. Schwartz, I. D. Waddell, B. R. Holloway, and M. B. Reid, “Skeletal muscle myocytes undergo protein loss and reactive oxygen- mediated NF-κB activation in response to tumor necrosis factor α,” FASEB Journal, vol. 12, no. 10, pp. 871–880, 1998. 15 [130] R. C. J. Langen, A. M. W. J. Schols, M. C. J. M. Kelders, E. F. M. Wouters, and Y. M. W. Janssen-Heininger, “Inﬂam- matory cytokines inhibit myogenic diﬀerentiation through activation of nuclear factor-κB,” FASEB Journal, vol. 15, no. 7, pp. 1169–1180, 2001. [131] D. C. Guttridge, C. Albanese, J. Y. Reuther, R. G. Pestell, and A. S. Baldwin, “NF-κB controls cell growth and diﬀer- entiation through transcriptional regulation of cyclin D1,” Molecular and Cellular Biology, vol. 19, no. 8, pp. 5785–5799, 1999. [132] D. C. Guttridge, M. W. Mayo, L. V. Madrid, C. Y. Wang, and A. S. Baldwin Jr., “NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia,” Science, vol. 289, no. 5488, pp. 2363–2365, 2000. [133] M. H. Parker, R. L. S. Perry, M. C. Fauteux, C. A. Berkes, and M. A. Rudnicki, “MyoD synergizes with the E-protein HEBβ to induce myogenic diﬀerentiation,” Molecular and Cellular Biology, vol. 26, no. 15, pp. 5771–5783, 2006. [134] H. Wang, E. Hertlein, N. Bakkar et al., “NF-κB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myoﬁbrillar genes,” Molecular and Cellular Biology, vol. 27, no. 12, pp. 4374–4387, 2007. [135] K. H. Lee, D. G. Kim, N. Y. Shin et al., “NF-κB-dependent expression of nitric oxide synthase is required for membrane fusion of chick embryonic myoblasts,” Biochemical Journal, vol. 324, part 1, pp. 237–242, 1997. [136] P. Kaliman, J. Canicio, X. Testar, M. Palac´ın, and A. Zorzano, “Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-κB and inducible nitric-oxide synthase deﬁne a common myogenic signaling pathway,” Journal of Biological Chemistry, vol. 274, no. 25, pp. 17437–17444, 1999. [137] S. Lee, E. Tak, J. Lee et al., “Mitochondrial H2O2 generated from electron transport chain complex i stimulates muscle diﬀerentiation,” Cell Research, vol. 21, no. 5, pp. 817–834, 2011. [138] E. Migliaccio, M. Giogio, S. Mele et al., “The p66(shc) adaptor protein controls oxidative stress response and life span in mammals,” Nature, vol. 402, no. 6759, pp. 309–313, 1999. [139] M. Trinei, M. Giorgio, A. Cicalese et al., “A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis,” Oncogene, vol. 21, no. 24, pp. 3872–3878, 2002. [140] P. Francia, C. Delli Gatti, M. Bachschmid et al., “Deletion of p66shc gene protects against age-related endothelial dysfunction,” Circulation, vol. 110, no. 18, pp. 2889–2895, 2004. [141] C. Napoli, I. Martin-Padura, F. de Nigris et al., “Deletion of the p66Shc longevity gene reduces systemic and tissue oxida- tive stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 4, pp. 2112–2116, 2003. [142] G. Zaccagnini, F. Martelli, P. Fasanaro et al., “p66ShcA mod- ulates tissue response to hindlimb ischemia,” Circulation, vol. 109, no. 23, pp. 2917–2923, 2004. [143] G. Zaccagnini, F. Martelli, A. Magenta et al., “p66ShcA and oxidative stress modulate myogenic diﬀerentiation and skeletal muscle regeneration after hind limb ischemia,” Journal of Biological Chemistry, vol. 282, no. 43, pp. 31453– 31459, 2007. [144] M. Fulco, R. L. Schiltz, S. Iezzi et al., “Sir2 regulates skeletal muscle diﬀerentiation as a potential sensor of the redox state,” Molecular Cell, vol. 12, no. 1, pp. 51–62, 2003.